These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38795936)

  • 41. Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.
    Peterson JF; Pfaller MA; Diekema DJ; Rinaldi MG; Riebe KM; Ledeboer NA
    J Clin Microbiol; 2011 May; 49(5):1765-71. PubMed ID: 21430096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.
    Dudiuk C; Berrio I; Leonardelli F; Morales-Lopez S; Theill L; Macedo D; Yesid-Rodriguez J; Salcedo S; Marin A; Gamarra S; Garcia-Effron G
    J Antimicrob Chemother; 2019 Aug; 74(8):2295-2302. PubMed ID: 31081031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
    Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Holliday N; Killian SB
    J Clin Microbiol; 2004 Feb; 42(2):718-21. PubMed ID: 14766842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection.
    Shields RK; Nguyen MH; Press EG; Cumbie R; Driscoll E; Pasculle AW; Clancy CJ
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7465-70. PubMed ID: 26392494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of the novel sixth
    Khan T; Faysal NI; Hossain MM; Mah-E-Muneer S; Haider A; Moon SB; Sen D; Ahmed D; Parnell LA; Jubair M; Chow NA; Chowdhury F; Rahman M
    Microbiol Spectr; 2024 Jul; 12(7):e0354023. PubMed ID: 38842332
    [No Abstract]   [Full Text] [Related]  

  • 49.
    Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
    J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
    [No Abstract]   [Full Text] [Related]  

  • 50. Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study.
    Cantón E; Pemán J; Gobernado M; Alvarez E; Baquero F; Cisterna R; Gil J; Martín-Mazuelos E; Rubio C; Sánchez-Sousa A; Serrano C
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1604-7. PubMed ID: 15793151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010.
    Huang YT; Liu CY; Liao CH; Chung KP; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3814-9. PubMed ID: 24752274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method.
    Cantón E; Pemán J; Iñiguez C; Hervás D; Lopez-Hontangas JL; Pina-Vaz C; Camarena JJ; Campos-Herrero I; García-García I; García-Tapia AM; Guna R; Merino P; Pérez del Molino L; Rubio C; Suárez A;
    J Clin Microbiol; 2013 Aug; 51(8):2691-5. PubMed ID: 23761155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of caspofungin susceptibility testing by the new Vitek 2 AST-YS06 yeast card using a unique collection of FKS wild-type and hot spot mutant isolates, including the five most common candida species.
    Astvad KM; Perlin DS; Johansen HK; Jensen RH; Arendrup MC
    Antimicrob Agents Chemother; 2013 Jan; 57(1):177-82. PubMed ID: 23089746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal susceptibility profile of invasive
    Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
    J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
    [No Abstract]   [Full Text] [Related]  

  • 55. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
    Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
    J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidrug-resistant endemic clonal strain of Candida auris in India.
    Chowdhary A; Anil Kumar V; Sharma C; Prakash A; Agarwal K; Babu R; Dinesh KR; Karim S; Singh SK; Hagen F; Meis JF
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):919-26. PubMed ID: 24357342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E; Hammarström H; Ataollahy N; Kondori N
    Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Candida auris: Clinical profile, diagnostic challenge and susceptibility pattern: Experience from a tertiary-care centre in South India.
    Ninan MM; Sahni RD; Chacko B; Balaji V; Michael JS
    J Glob Antimicrob Resist; 2020 Jun; 21():181-185. PubMed ID: 31655136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
    Lockhart SR; Etienne KA; Vallabhaneni S; Farooqi J; Chowdhary A; Govender NP; Colombo AL; Calvo B; Cuomo CA; Desjardins CA; Berkow EL; Castanheira M; Magobo RE; Jabeen K; Asghar RJ; Meis JF; Jackson B; Chiller T; Litvintseva AP
    Clin Infect Dis; 2017 Jan; 64(2):134-140. PubMed ID: 27988485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.